Clin2
NCT06930495Possibly a fitEnrolling by invitation

Weight loss and heart failure with normal pumping strength

Heart Failure With Preserved Ejection Fraction (HFPEF)

Part of Hormones & metabolism clinical trials.

This study tests whether weight loss treatments can improve muscle and blood vessel function in people with a specific type of heart failure (HFpEF) who also have obesity. It may help if you have heart failure with a normal ejection fraction and a high BMI.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
95 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You have a diagnosis of heart failure or a recent hospitalization for heart failure.
  • Your heart's ejection fraction (pumping strength) is above 50%.
  • You have evidence of high pressure in the left side of your heart during exercise.
  • Your BMI is over 32, and you are eligible for intensive weight loss treatments like certain diabetes medications.
  • You have not taken incretin-based drugs (like SGLT2 or GLP-1) in the past 6 months.
  • You are 45 years or older.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07493590Not yet recruiting
Finding hidden heart failure with normal pumping strength

This study looks for people who may have a type of heart failure where the heart pumps normally but still doesn't work well. It aims to better understand who gets this condition and how to spot it earlier.

Copenhagen
NCT07642921Not yet recruiting
Understanding Heart Failure With Normal Pumping Function

This study helps doctors better understand a type of heart failure where the heart pumps normally but has trouble relaxing and filling with blood. Researchers will use ultrasound, blood tests, and clinical information to identify different subtypes and improve treatment.

NCT07761117Not yet recruiting· Phase 3
Heart failure treatment study for people with preserved pumping function

This study tests an investigational medication called elecoglipron to see if it can improve heart and blood vessel outcomes in people with heart failure with preserved or mildly reduced ejection fraction. If you join, you will receive either the study drug or a placebo, and your heart health will be monitored over time.

Fairhope, Alabama
NCT07251361Enrolling by invitation
Exercise program for heart failure with preserved ejection fraction

This study tests whether a special exercise program that combines different types of training (like aerobic, strength, and balance) can improve heart and muscle function, daily abilities, and quality of life in people with heart failure with preserved ejection fraction (HFpEF). You may benefit if your heart failure is stable and you are able to exercise safely.

Pamplona, Navarre
NCT07052539Recruiting
Kidney disease in heart failure with obesity

This study looks at how kidney disease relates to a type of heart failure (called HFpEF) that often happens in people with obesity. It will help doctors understand this connection better.

Jackson, Mississippi
NCT06768437Recruiting
Heart fat and preserved ejection fraction heart failure trial

This study looks at whether fat around the heart affects a type of heart failure where the heart pumps well but is stiff (HFpEF). You may be able to join if you have this condition, are 18 or older, and can understand English.

Leicester, Leicestershire

Hear when a new Heart Failure With Preserved Ejection Fraction (HFPEF) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.